University of Colorado Department of Medicine
A

SGLT2 Inhibitors: Mechanisms of Behind the Mortality Benefit

By University of Colorado Department of Medicine FEATURING Amy Li
By University of Colorado Department of Medicine FEATURING Amy Li
1,314 views
May 23, 2022
Comments 2
Login to view comments. Click here to Login

Featured Video

05:11
Novartis Cardiology

Initiating and Monitoring Patients on a Non-Statin Lipid-Lowering Th…

Feat. R. Sugumaran, P. Shah, S. Shugg

Featured Video

13:03
Novartis Cardiology

Expert Insights on Adding a Non-Statin Lipid-Lowering Therapy in a R…

Feat. M. Koren

Related Videos

64:45

Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

44.4K views
11:37

ACC 2022: An Embarrassment of Riches - Updated Guideline Recommendat…

ACC 2022 Conference Coverage

P. Heidenreich

22.5K views
11:25

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

20.9K views
18:43

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

12.2K views
37:21

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

10.7K views
26:01

Renal, Metabolic and Cardiovascular Considerations of SGLT2 Inhibiti…

Cardiology Fiesta 2017

R. DeFronzo

9.5K views
08:35

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

7.8K views
17:44

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

Rita Jermyn

8.5K views
27:24

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

8.7K views
15:11

New

Early Detection & The Delay and Prevention of T1D

Thomas Blevins

28 views
07:41

Weightloss in Menopause

Susan Brian

6.3K views
26:49

Tirzepatide Updates

Diana Isaacs

8.1K views
33:23

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Keck School of Medicine of USC

M. Goran

7.3K views
38:25
Omnipod®

Mind over diabetes: a psychologist’s take on the freedom of Omnipod®…

Feat. M. Heyman
05:08

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

3.3K views
45:34
Omnipod®

Advancing Type 2 Diabetes Care with Omnipod® 5

Feat. V. Shah, D. Kruger, T. Ly
20:15
Omnipod®

Type 2 Diabetes and Omnipod® 5--Unveiling SECURE T2D

Feat. F. Pasquel
06:31

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

3.5K views
09:44

Mounjaro Update 2024

Susan Brian

92 views
30:11
Omnipod®

Optimizing Omnipod® 5 for Better Patient Outcomes (featuring Jennife…

Feat. J. Okemah
AUTOPLAY